. Author manuscript; available in PMC: 2023 Sep 12.

Published in final edited form as: Vaccine. 2021 Dec 23;40(Suppl 1):A77–A84. doi: 10.1016/j.vaccine.2021.11.057

Table 5.

Cost of Human Papillomavirus Vaccine Delivery in a Single-Age Cohort, Routine-Based Vaccination Program in Senegal; Cost by Payer (Excluding the Cost of Vaccine Program Activity), May 2018–March 2020

	FINANCIAL		ECONOMIC
	Total Weighted Financial Costs (US$)	% of Total	Total Weighted Economic Costs (US$)	% of Total

Ministry of Health	$702,853	61%	$1,598,929	56%
CDS	$239,485	21%	$482,119	17%
Ministry of Education	$5,684	<1%	$334,705	12%
WHO	$53,375	5%	$52,639	2%
Other Government	$3,350	<1%	$8,067	<1%
UNICEF	$45,994	4%	$46,063	2%
Other	$20,195	2%	$166,022	6%
Unknown ^*	$81,412	7%	$139,170	5%
TOTAL	$1,152,351	100%	$2,838,466	100%

Note: Data are presented in 2020 US dollars.

Unknown indicates that payer information was not collected or not asked. Abbreviations: WHO: World Health Organization; UNICEF: United Nations International Children’s Emergency Fund; CDS: Comité de Développement Sanitaire.